RIGEL
LIVE

Serial Number

87844169

Owner

Rigel Pharmaceuticals, Inc.

Attorney

James J. Saul

First Use Date

May 30, 2018

Filing Date

Mar 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

RIGEL Trademark

Serial Number: 87844169 • Registration: 5921715

RIGEL is a trademark filed by Rigel Pharmaceuticals, Inc. on March 21, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Rigel Pharmaceuticals, Inc. (27 trademarks)

772 Lucerne Drive
Sunnyvale, CA 94086

Entity Type: 03

Trademark Details

Filing Date

March 21, 2018

Registration Date

November 26, 2019

First Use Anywhere

May 30, 2018

First Use in Commerce

May 30, 2018

Published for Opposition

February 19, 2019

Goods & Services

printed publications, namely, reports, manuals, brochures, newsletters and leaflets in the field of medicine, research and pharmaceuticals

Providing a website featuring information for medical professionals, pharmacies, and consumers regarding therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring medical information related to inflammatory disease and disorders, immune system disease and disorders, metabolic disease and disorders, dermatological and hematological disease and disorders, cancer and rare diseases

research and development of technologies and scientific data in the field of new drug development for others; Medical and scientific research in the field inflammatory disease and disorders, immune system disease and disorders, metabolic disease and disorders, dermatological and hematological disease and disorders, cancer and rare diseases; Providing a website featuring scientific research information related to inflammatory disease and disorders, immune system disease and disorders, metabolic disease and disorder, dermatological and hematological diseases and disorders, cancer and rare diseases

pharmaceutical preparations for the treatment of cancer, immune disorders, inflammation, rare diseases, genetic diseases, and auto-immune diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 26, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 26, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 20, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 26, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2023 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 25, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 22, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 21, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 8, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 8, 2019 AITU
USE AMENDMENT FILED
Sep 19, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 19, 2019 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2019 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 16, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 2, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 2, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 2, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 2, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2018 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2018 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 20, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 20, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 20, 2018 CNRT
ASSIGNED TO EXAMINER
Jun 12, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 29, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2018 NWOS
NEW APPLICATION ENTERED
Mar 24, 2018 NWAP